Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 23 crawled time : 19:00 save search
US Patent Office Grants Patent for COVID-19 Risk Test
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
GENE | News 0 d | $2.33 -4.51% 21K
|
Health Technology
|
| O: -2.62%
H: 4.51%
C: 2.69%
covid-19 risk patent covid test grant granted
How Storyblocks Enabled a New Class of Event-Driven Microservices with Confluent
Published: 2022-02-23 (Crawled : 19:00) - confluent.io
FLNT | News | $2.6 2.77% 3.7K
|
Technology Services
|
| O: -4.0%
H: 13.33%
C: 12.5%
ces services
How to Create a Facebook Announcement
Published: 2022-02-23 (Crawled : 19:00) - shutterstock.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: -2.2%
H: 0.0%
C: -0.14%
announcement
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Therapies
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
NTLA | $21.54 1.03% 85K
|
Health Technology
|
| O: 1.57%
H: 1.39%
C: -6.39%
therapeutics crispr intel therapy
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational BiologyGenomics Industry Veteran to Oversee Development of Robust Computational Biology Program
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PACB | $1.49 2.05% 1.5M
|
Health Technology
|
| O: 3.78%
H: 1.12%
C: -6.26%
genomics genomic program computational
Amylyx Pharmaceuticals Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
AMLX | $2.015 1.77% 150K
|
|
| O: -3.54%
H: 5.46%
C: 0.1%
als
Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.015 0.75% 40K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: -3.95%
day technology therapeutics test set
Esports Entertainment Group to Install OMEGA at GAMMAX Locations in the Netherlands
Published: 2022-02-23 (Crawled : 19:00) - esportsentertainmentgroup.com
GMBL | $0.75 8.5K
|
Consumer Services
|
| O: -13.71%
H: 18.69%
C: 15.89%
netherlands group
4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
LBPS | $1.65 -0.61%
|
Manufacturing
|
| O: 4.27%
H: 0.0%
C: -5.92%
genomics genomic pharma
aTyr Pharma to Participate in Panel at National Institutes of Health Rare Disease Day®Panel to take place on Monday, February 28, 2022, at 2:55pm EST / 11:55am PST
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
LIFE | $1.615 -0.31% 49K
|
Health Technology
|
| O: 1.37%
H: 0.19%
C: -2.71%
day health rare disease
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
CO | $2.9876 -2.1%
|
Health Services
|
| O: 0.24%
H: 1.18%
C: -1.18%
blood financial results corporation report results
Pieris Pharmaceuticals To Host Full-Year 2021 Investor Call and Provide Corporate Update on March 1, 2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PIRS | $0.153 -1.42% 680K
|
Health Technology
|
| O: 1.32%
H: 5.21%
C: -1.95%
als
Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
RANI | $6.14 1.49% 54K
|
|
| O: 3.45%
H: 8.59%
C: -11.52%
financial results device liver therapeutics report results
Clovis Oncology Announces 2021 Operating Results and Anticipated 2022 Development Milestones
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 1.18%
H: 0.88%
C: -5.26%
one milestone
Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
ALIM | $3.44 5.7K
|
Health Technology
|
| O: -2.37%
H: 5.43%
C: 2.86%
iluvien
Horizon Therapeutics plc Initiates Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating Teprotumumab for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.97%
H: 0.38%
C: -2.35%
treatment eye eye disease trial therapeutics disease active phase 3
Canadian Pacific announces filing of 2021 Form 10-K
Published: 2022-02-23 (Crawled : 19:00) - prnewswire.com
CP | $84.61 0.8% 79K
|
Transportation
|
| O: -2.38%
H: 2.56%
C: 2.23%
ces
Mr. Block Announces Debut of New Ecommerce Website
Published: 2022-02-23 (Crawled : 19:00) - prnewswire.com
CRCW | $0.0015 8.5M
|
Information
|
| O: -0.44%
H: 12.33%
C: 3.96%
ces
ForeverLawn's Black and Green Grass Machine to Feature Harvest Ministries at Auto Club Speedway
Published: 2022-02-23 (Crawled : 19:00) - prnewswire.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: -2.2%
H: 0.0%
C: -0.14%
Ayala Pharmaceuticals Announces Completion of Enrollment in Part A of RINGSIDE, a Pivotal Phase 2/3 Study of AL102 in Desmoid TumorsInterim Results expected mid-2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: -4.52%
H: 7.35%
C: -4.98%
al102 phase 2 als phase 2/3 enroll
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.